Edgewise Therapeutics Inc (EWTX)
R&D Expenses
$47.55M
Quarterly · Period ending: · USD
EWTX R&D Expenses
Latest reported$47.55Mperiod ending
Latest reported$47.55Mperiod ending
EWTX Quarterly R&D Expenses ($2.97M → $47.55M)
Quarterly R&D Expenses
High-resolution chart · PNG
EWTX r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 47,548,000 | |
| 42,651,000 | |
| 43,594,000 | |
| 37,480,000 | |
| 33,558,000 | |
| 36,757,000 | |
| 36,370,000 | |
| 32,222,000 | |
| 30,680,000 | |
| 27,694,000 | |
| 27,684,000 | |
| 23,786,000 | |
| 19,559,000 | |
| 19,876,000 | |
| 16,612,000 | |
| 13,894,000 | |
| 12,402,000 | |
| 11,124,000 | |
| 9,088,000 | |
| 9,880,000 | |
| 7,861,000 | |
| 5,360,000 | |
| 5,139,000 | |
| 3,238,000 | |
| 3,639,000 | |
| 2,967,000 |